Pharmacological treatment of idiopathic pulmonary fibrosis – preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine

por Myllärniemi, Marjukka, Kaarteenaho, Riitta
Publicado 2015

Overall drug treatment of idiopathic pulmonary fibrosis patients from national registries – a real-world study from Finland

por Kaunisto, Jaana, Salomaa, Eija-Riitta, Koivisto, Mari, Myllärniemi, Marjukka
Publicado 2023

Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: Current and future perspectives

por Louhelainen, Noora, Myllärniemi, Marjukka, Rahman, Irfan, Kinnula, Vuokko L
Publicado 2008

Idiopathic pulmonary fibrosis - a systematic review on methodology for the collection of epidemiological data

por Kaunisto, Jaana, Salomaa, Eija-Riitta, Hodgson, Ulla, Kaarteenaho, Riitta, Myllärniemi, Marjukka
Publicado 2013

Are physicians in primary health care able to recognize pulmonary fibrosis?

por Purokivi, Minna, Hodgson, Ulla, Myllärniemi, Marjukka, Salomaa, Eija-Riitta, Kaarteenaho, Riitta
Publicado 2017

mMRC dyspnoea scale indicates impaired quality of life and increased pain in patients with idiopathic pulmonary fibrosis

por Rajala, Kaisa, Lehto, Juho T., Sutinen, Eva, Kautiainen, Hannu, Myllärniemi, Marjukka, Saarto, Tiina
Publicado 2017

Evidence for marked underutilization of insurance billing in malignant pleural mesothelioma in Finland

por Torkki, Paulus, Paajanen, Juuso, Kytö, Ville, Laaksonen, Sanna, Räsänen, Jari, Myllärniemi, Marjukka, Ilonen, Ilkka
Publicado 2021

Increased oxidative stress in asymptomatic current chronic smokers and GOLD stage 0 COPD

por Rytilä, Paula, Rehn, Tiina, Ilumets, Helen, Rouhos, Annamari, Sovijärvi, Anssi, Myllärniemi, Marjukka, Kinnula, Vuokko L
Publicado 2006

Hemoglobin α and β are ubiquitous in the human lung, decline in idiopathic pulmonary fibrosis but not in COPD

por Ishikawa, Nobuhisa, Ohlmeier, Steffen, Salmenkivi, Kaisa, Myllärniemi, Marjukka, Rahman, Irfan, Mazur, Witold, Kinnula, Vuokko L
Publicado 2010

Delay and inequalities in the treatment of idiopathic pulmonary fibrosis: the case of two Nordic countries

por Pesonen, Ida, Carlson, Lisa, Murgia, Nicola, Kaarteenaho, Riitta, Sköld, Carl Magnus, Myllärniemi, Marjukka, Ferrara, Giovanni
Publicado 2018

Organisation of diagnosis and treatment of idiopathic pulmonary fibrosis and other interstitial lung diseases in the Nordic countries

por Bendstrup, Elisabeth, Hyldgaard, Charlotte, Altraja, Alan, Sjåheim, Tone, Myllärniemi, Marjukka, Gudmundsson, Gunnar, Sköld, Magnus, Hilberg, Ole
Publicado 2015

Pirfenidone decreases mesothelioma cell proliferation and migration via inhibition of ERK and AKT and regulates mesothelioma tumor microenvironment in vivo

por Li, Chang, Rezov, Veronika, Joensuu, Emmi, Vartiainen, Ville, Rönty, Mikko, Yin, Miao, Myllärniemi, Marjukka, Koli, Katri
Publicado 2018

Label-free plasma proteomics identifies haptoglobin-related protein as candidate marker of idiopathic pulmonary fibrosis and dysregulation of complement and oxidative pathways

por Saraswat, Mayank, Joenväärä, Sakari, Tohmola, Tiialotta, Sutinen, Eva, Vartiainen, Ville, Koli, Katri, Myllärniemi, Marjukka, Renkonen, Risto
Publicado 2020

KIF15 missense variant is associated with the early onset of idiopathic pulmonary fibrosis

por Hollmén, Maria, Laaka, Atte, Partanen, Juulia J., Koskela, Jukka, Sutinen, Eva, Kaarteenaho, Riitta, Ainola, Mari, Myllärniemi, Marjukka
Publicado 2023

Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry

por Kaunisto, Jaana, Salomaa, Eija-Riitta, Hodgson, Ulla, Kaarteenaho, Riitta, Kankaanranta, Hannu, Koli, Katri, Vahlberg, Tero, Myllärniemi, Marjukka
Publicado 2019

Matrix metalloproteinases -8, -9 and -12 in smokers and patients with Stage 0 COPD

por Ilumets, Helen, Rytilä, Paula, Demedts, Ingel, Brusselle, Guy G, Sovijärvi, Anssi, Myllärniemi, Marjukka, Sorsa, Timo, Kinnula, Vuokko L
Publicado 2007

Gremlin-1 Overexpression in Mouse Lung Reduces Silica-Induced Lymphocyte Recruitment – A Link to Idiopathic Pulmonary Fibrosis through Negative Correlation with CXCL10 Chemokine

por Koli, Katri, Sutinen, Eva, Rönty, Mikko, Rantakari, Pia, Fortino, Vittorio, Pulkkinen, Ville, Greco, Dario, Sipilä, Petra, Myllärniemi, Marjukka
Publicado 2016

Prognostic role of radiological peritoneal cancer index in malignant peritoneal mesothelioma: national cohort study

por Salo, Silja A. S., Lantto, Eila, Robinson, Eric, Myllärniemi, Marjukka, Laaksonen, Sanna, Salo, Jarmo A., Rantanen, Tuomo, Ilonen, Ilkka
Publicado 2020

Upregulation of activin-B and follistatin in pulmonary fibrosis – a translational study using human biopsies and a specific inhibitor in mouse fibrosis models

por Myllärniemi, Marjukka, Tikkanen, Jussi, Hulmi, Juha J, Pasternack, Arja, Sutinen, Eva, Rönty, Mikko, Leppäranta, Outi, Ma, Hongqiang, Ritvos, Olli, Koli, Katri
Publicado 2014

Gremlin-1 is a key regulator of the invasive cell phenotype in mesothelioma

por Yin, Miao, Tissari, Mira, Tamminen, Jenni, Ylivinkka, Irene, Rönty, Mikko, von Nandelstadh, Pernilla, Lehti, Kaisa, Hyytiäinen, Marko, Myllärniemi, Marjukka, Koli, Katri
Publicado 2017